Allied Minds (LON:ALM) had its price target trimmed by Credit Suisse Group from GBX 175 ($2.42) to GBX 110 ($1.52) in a research note issued to investors on Friday. The firm currently has a neutral rating on the stock.
Separately, Numis Securities reissued an add rating and set a GBX 187 ($2.58) target price on shares of Allied Minds in a research note on Monday, January 22nd.
Allied Minds (LON:ALM) opened at GBX 109.98 ($1.52) on Friday. The firm has a market capitalization of $291.76 and a price-to-earnings ratio of -343.69. Allied Minds has a twelve month low of GBX 115 ($1.59) and a twelve month high of GBX 390.20 ($5.39).
Allied Minds Company Profile
Allied Minds PLC (Allied Minds) is an intellectual property (IP) commercialization company. The Company is focused on venture creation within the life science and technology sectors. With extensive access to hundreds of university and federal laboratories across the United States, Allied Minds forms, funds, and operates a portfolio of companies to generate long-term value for its investors and stakeholders.
Receive News & Ratings for Allied Minds Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allied Minds and related companies with MarketBeat.com's FREE daily email newsletter.